Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Berlico Mulia Farma is an Indonesian pharmaceutical company based in Yogyakarta that specializes in the development and manufacturing of generic and over-the-counter (OTC) medications. Since its acquisition by PT Industri Jamu dan Farmasi Sido Muncul Tbk in 2014, the company has served as the pharmaceutical arm of the group, diversifying its portfolio into ethical drugs and consumer health products. The company operates a manufacturing facility that is certified for Good Manufacturing Practices (CPOB) by the Indonesian FDA (BPOM). Its product range includes analgesics, antibiotics, vitamins, and treatments for metabolic and respiratory conditions. Berlico focuses on providing affordable healthcare solutions to the Indonesian market through an extensive distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Berlico Mulia Farma.